Literature DB >> 23066027

STAT3 protein up-regulates Gα-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasis.

Ying Dunkel1, Andrew Ong, Dimple Notani, Yash Mittal, Michael Lam, Xiaoyi Mi, Pradipta Ghosh.   

Abstract

Gα-interacting vesicle-associated protein (GIV) is a guanine nucleotide exchange factor that modulates key signaling pathways during a diverse set of biological processes, e.g. wound healing, macrophage chemotaxis, tumor angiogenesis, vascular repair, and cancer invasion/metastasis. We recently demonstrated that GIV is a metastasis-related protein, which serves both as a therapeutic target and as a biomarker for prognostication in cancer patients. Here we report the discovery that GIV is a direct target of the transcription factor signal transducer and activator of transcription-3 (STAT3), which is commonly known as a central regulator of tumor metastasis. We identified a single STAT3-binding site on the GIV promoter that was necessary and sufficient for transcriptional activation of GIV during wound healing and cancer invasion. Immunohistochemical analysis of breast carcinomas showed significant correlation between STAT3 activation and elevated GIV expression. Furthermore, we provide evidence that GIV positively autoregulates its own transcription by enhancing STAT3 activation via its guanine nucleotide exchange factor activity. Our findings provide mechanistic insights into how STAT3 activation is directly integrated with the receptor tyrosine kinase-GIV-G protein signaling axis. The forward feedback regulation we describe here between GIV and STAT3 may have profound therapeutic implications for cancer and epithelial regeneration/repair and could help invent novel approaches in treating and prognosticating cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23066027      PMCID: PMC3516717          DOI: 10.1074/jbc.M112.390781

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

2.  Stat3 dimerization regulated by reversible acetylation of a single lysine residue.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Devasis Chatterjee; Y Eugene Chin
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

3.  An animal model for colon cancer metastasis: establishment and characterization of murine cell lines with enhanced liver-metastasizing ability.

Authors:  R S Bresalier; E S Hujanen; S E Raper; F J Roll; S H Itzkowitz; G R Martin; Y S Kim
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

4.  Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation.

Authors:  Jinbo Yang; Moitreyee Chatterjee-Kishore; Susan M Staugaitis; Hannah Nguyen; Karni Schlessinger; David E Levy; George R Stark
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

5.  Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1.

Authors:  C A Cantwell; E Sterneck; P F Johnson
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

Review 6.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

7.  Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis.

Authors:  Tong-Xin Xie; Daoyan Wei; Mingguang Liu; Allen C Gao; Francis Ali-Osman; Raymond Sawaya; Suyun Huang
Journal:  Oncogene       Date:  2004-04-29       Impact factor: 9.867

8.  Temporal patterns of gene expression in murine cutaneous burn wound healing.

Authors:  Robert J Feezor; Heather N Paddock; Henry V Baker; Juan C Varela; Joyce Barreda; Lyle L Moldawer; Gregory S Schultz; David W Mozingo
Journal:  Physiol Genomics       Date:  2004-02-13       Impact factor: 3.107

9.  Inhibition of transcription factor binding to the HER2 promoter by triplex-forming oligodeoxyribonucleotides.

Authors:  S B Noonberg; G K Scott; C A Hunt; M E Hogan; C C Benz
Journal:  Gene       Date:  1994-11-04       Impact factor: 3.688

10.  Tumor progression in four mammary epithelial cell lines derived from the same patient.

Authors:  V Band; D Zajchowski; K Swisshelm; D Trask; V Kulesa; C Cohen; J Connolly; R Sager
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

View more
  28 in total

Review 1.  Heterotrimeric G protein signaling via GIV/Girdin: Breaking the rules of engagement, space, and time.

Authors:  Nicolas Aznar; Nicholas Kalogriopoulos; Krishna K Midde; Pradipta Ghosh
Journal:  Bioessays       Date:  2016-02-16       Impact factor: 4.345

2.  Biochemical, Biophysical and Cellular Techniques to Study the Guanine Nucleotide Exchange Factor, GIV/Girdin.

Authors:  Pradipta Ghosh; Nicolas Aznar; Lee Swanson; I-Chung Lo; Inmaculada Lopez-Sanchez; Jason Ear; Cristina Rohena; Nicholas Kalogriopoulos; Linda Joosen; Ying Dunkel; Nina Sun; Peter Nguyen; Deepali Bhandari
Journal:  Curr Protoc Chem Biol       Date:  2016-12-07

3.  Expression of Girdin in primary hepatocellular carcinoma and its effect on cell proliferation and invasion.

Authors:  Ke Cao; Can Lu; Shuang Han; Qiong Zou; Jingjing Li; Dingfang Xie; Siqi He; Li Yu; Jianda Zhou; Xiaowei Peng; Peiguo Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  Therapeutic effects of cell-permeant peptides that activate G proteins downstream of growth factors.

Authors:  Gary S Ma; Nicolas Aznar; Nicholas Kalogriopoulos; Krishna K Midde; Inmaculada Lopez-Sanchez; Emi Sato; Ying Dunkel; Richard L Gallo; Pradipta Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-29       Impact factor: 11.205

Review 5.  RANK-mediated signaling network and cancer metastasis.

Authors:  Gina Chia-Yi Chu; Leland W K Chung
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

6.  G protein coupled growth factor receptor tyrosine kinase: no longer an oxymoron.

Authors:  Pradipta Ghosh
Journal:  Cell Cycle       Date:  2015-06-30       Impact factor: 4.534

7.  Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers.

Authors:  Ying Dunkel; Kexin Diao; Nicolas Aznar; Lee Swanson; Lawrence Liu; Wenhong Zhu; Xiao-Yi Mi; Pradipta Ghosh
Journal:  FASEB J       Date:  2016-07-20       Impact factor: 5.191

Review 8.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

9.  Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin.

Authors:  Ya-Jie Zhang; A-Jian Li; Yi Han; Lu Yin; Mou-Bin Lin
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

10.  Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer.

Authors:  Pradipta Ghosh; Jeanne Tie; Andrea Muranyi; Shalini Singh; Patrick Brunhoeber; Katherine Leith; Rebecca Bowermaster; Zhiming Liao; Yifei Zhu; Bonnie LaFleur; Ben Tran; Jayesh Desai; Ian Jones; Matthew Croxford; Rodrigo Jover; Ajay Goel; Paul Waring; Song Hu; Volker Teichgraber; Ulrich-Peter Rohr; Ruediger Ridder; Kandavel Shanmugam; Peter Gibbs
Journal:  Clin Cancer Res       Date:  2016-03-30       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.